Credit Suisse’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | -$3 | – | 3811 |
|
|
2022
Q4 | – | Sell |
-3,776
| Closed | -$66.6K | – | 3877 |
|
|
2022
Q3 | $80K | Buy |
3,776
+34
| +0.9% | +$917 | ﹤0.01% | 3479 |
|
|
2022
Q2 | $90K | Buy |
3,742
+47
| +1% | +$1.6K | ﹤0.01% | 3556 |
|
|
2022
Q1 | $184K | Buy |
3,695
+241
| +7% | +$11.9K | ﹤0.01% | 3390 |
|
|
2021
Q4 | $241K | Buy |
3,454
+99
| +3% | +$8.34K | ﹤0.01% | 4209 |
|
|
2021
Q3 | $313K | Buy |
3,355
+357
| +12% | +$33.9K | ﹤0.01% | 4072 |
|
|
2021
Q2 | $301K | Sell |
2,998
-2,550
| -46% | -$249K | ﹤0.01% | 4109 |
|
|
2021
Q1 | $518K | Sell |
5,548
-14,631
| -73% | -$1.48M | ﹤0.01% | 3748 |
|
|
2020
Q4 | $1.67M | Sell |
20,179
-3,556
| -15% | -$303K | ﹤0.01% | 2960 |
|
|
2020
Q3 | $2.04M | Buy |
23,735
+23,095
| +3,609% | +$2.69M | ﹤0.01% | 2415 |
|
|
2020
Q2 | $60K | Buy |
+640
| New | +$35.3K | ﹤0.01% | 3866 |
|
|
2020
Q1 | – | Sell |
-2,453
| Closed | -$102K | – | 4303 |
|
|
2019
Q4 | $102K | Buy |
2,453
+1,780
| +264% | +$39K | ﹤0.01% | 4068 |
|
|
2019
Q3 | $9K | Buy |
673
+241
| +56% | +$5.05K | ﹤0.01% | 4095 |
|
|
2019
Q2 | $15K | Sell |
432
-1,272
| -75% | -$69K | ﹤0.01% | 4054 |
|
|
2019
Q1 | $96K | Buy |
1,704
+1,371
| +412% | +$74.2K | ﹤0.01% | 3847 |
|
|
2018
Q4 | $16K | Buy |
+333
| New | +$18.3K | ﹤0.01% | 3838 |
|
|
2018
Q2 | – | Sell |
-534
| Closed | -$56K | – | 4183 |
|
|
2018
Q1 | $56K | Buy |
+534
| New | +$63.7K | ﹤0.01% | 3871 |
|
|
2017
Q4 | – | Sell |
-490
| Closed | -$57K | – | 4247 |
|
|
2017
Q3 | $57K | Buy |
+490
| New | +$58.9K | ﹤0.01% | 4138 |
|
|
2017
Q2 | – | Sell |
-375
| Closed | -$62K | – | 3993 |
|
|
2017
Q1 | $62K | Buy |
+375
| New | +$50.8K | ﹤0.01% | 3729 |
|
Other funds holding VBIV
PA
GAI
